Definium Therapeutics, Inc. (DFTX)
24.19
+0.71
(+3.02%)
USD |
NASDAQ |
May 29, 16:00
24.03
-0.16
(-0.66%)
After-Hours: 20:00
Definium Therapeutics Total Assets (Quarterly) : 401.29M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 7.426M |
| CNBX Pharmaceuticals, Inc. | 0.0149M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 647.50M |
| Fulcrum Therapeutics, Inc. | 346.77M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 122.44M |
| Shareholders Equity (Quarterly) | 278.85M |
| Debt to Equity Ratio | 0.1462 |
| Current Ratio | 4.692 |
| Net Debt Paydown Yield | -0.19% |